🇺🇸 Simvastatin 20mg in United States

122 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myalgia — 29 reports (23.77%)
  2. Fatigue — 14 reports (11.48%)
  3. Pain In Extremity — 14 reports (11.48%)
  4. Drug Interaction — 11 reports (9.02%)
  5. Muscle Spasms — 11 reports (9.02%)
  6. Abdominal Discomfort — 9 reports (7.38%)
  7. Arthralgia — 9 reports (7.38%)
  8. Asthenia — 9 reports (7.38%)
  9. Blood Creatine Phosphokinase Increased — 8 reports (6.56%)
  10. Dizziness — 8 reports (6.56%)

Source database →

Simvastatin 20mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Simvastatin 20mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Simvastatin 20mg in United States?

University of Oxford is the originator. The local marketing authorisation holder may differ — check the official source linked above.